HDFC Life's Half-Year Profit Rises 13% to Rs 1,119 Crore as New Business Value Grows 12%, While Proposed Expense Rules Loom

HDFC Life Insurance reported higher profit and new business value for the six months ended September 30, 2026, while telling investors it expects some disruption from proposed changes to the way Indian regulators limit insurers' costs. The company's board approved the results on October 15, 2026. This article draws on three secondary reports of the company's disclosures, from ScanX, Kalkine and Whalesbook. Only the half-year figures are given in detail, and the reports do not provide separate standalone figures for the second quarter, so this article does not either. Readers who want exact numbers should consult the filing on the stock exchanges.

The headline numbers, according to ScanX, are these. Profit after tax for the half-year was Rs 1,119 crore, up about 13% from Rs 994 crore a year earlier. Value of new business, or VNB, which estimates the present value of profits from policies sold in the period, was Rs 2,037 crore, up about 12% from Rs 1,818 crore. The VNB margin, which is VNB divided by annualised premium equivalent, was 24.7%, compared with 24.5%. Annualised premium equivalent, a measure of new business sales that puts single and regular premiums on a common annual basis, was Rs 8,245 crore, up 11% from Rs 7,413 crore, and individual annualised premium equivalent was Rs 7,080 crore, up 9%. Total premium income was Rs 39,569 crore, up 16%. Assets under management were Rs 4,09,673 crore, up 14% from Rs 3,59,999 crore, and Indian embedded value, a measure of the value of the existing business plus net assets, was Rs 66,461 crore, up 12%.

A few of the quality indicators moved the wrong way. The total expense ratio rose to 22.3% from 21.6%. The 13-month persistency ratio, which shows the share of policies still in force after a year, fell to 83% from 86%. The 61-month persistency ratio improved to 66% from 62%, which suggests that longer-term policyholders are staying. The solvency ratio, a regulatory measure of capital strength, rose to 180% from 175%. Renewal collections grew 14%. In protection, retail protection grew 33% and made up about 8% of individual annualised premium equivalent, compared with about 7% a year earlier. ScanX also reports that individual weighted received premium grew 11% in the second quarter, compared with a private-industry average of 10%, and that the company's market share rose to 16.2% from 16.1% in the first quarter.

The board also approved two corporate actions, according to Kalkine. It gave in-principle approval for the issue of subordinated non-convertible debentures of up to Rs 500 crore, in one or more tranches on a private placement basis, with the final size, coupon and timing not yet disclosed. Subordinated debt counts toward an insurer's regulatory capital and ranks below policyholders and other creditors. The board also approved setting up an insurance office in the GIFT City international financial services centre in Gujarat, which needs approval from the Insurance Regulatory and Development Authority of India, the IFSC Authority and shareholders through a postal ballot. No dividend recommendation was made at the meeting.

The more significant story is the regulatory backdrop. According to Whalesbook, the Insurance Regulatory and Development Authority of India has proposed stricter limits on management expenses and distributor commissions, with the central item being the expense of management limits that cap how much insurers can spend on distribution, advertising and administration. The report does not give the proposed cap levels or a date for final notification. Our earlier coverage of the proposals in this series described them as caps on commissions that regulators are still weighing, and they should be treated as proposals until the regulator issues final rules. HDFC Life's management, as paraphrased by Whalesbook, said it expects a period of operational adjustment and is prepared to adapt. It cited an expense ratio of roughly 21% for the recent quarter, a figure that is not directly comparable with the 22.3% half-year ratio reported by ScanX because the periods differ. Management said it prefers to manage adjustments through market dynamics rather than fixed numerical targets, pointed to the 2017 changes to commission structures as a precedent in which the industry kept growing, especially through banks, and said it relies on its product mix, including a growing annuity portfolio and a stable bancassurance network, to absorb volatility. It also expects the upcoming risk-based capital framework to ease solvency constraints. These are paraphrases of remarks by management, not direct quotes.

What does this mean for policyholders? If final rules cut the amount insurers can spend on distribution, the effect could appear in several places. Commissions paid to agents and banks could fall, which might change who sells which products and how hard they are pushed. Insurers might redesign products to keep margins, or pass some savings to customers, though the reports reviewed do not say which is more likely. For customers, the useful advice does not change. Compare premiums and benefits across insurers, check the claim settlement record, and avoid buying a product simply because it earns a high commission for the seller. The fall in 13-month persistency at HDFC Life is a reminder to buy only what you can afford to keep paying, since early lapses often mean lost money.

What should investors watch? The key variables are the final form and timing of the expense rules, the trend in the VNB margin as costs and mix change, and persistency, which affects long-term profit. The reports include some views on risks, such as margin pressure if rules require significant spending cuts and the possibility that distributors need time to adjust to new payout models, which could reduce volumes. This article describes company-reported results and is not investment advice.

HDFC Life's results arrive two days after ICICI Life's, which we covered separately. Together they suggest that the largest private life insurers are growing profits at a double-digit pace, with protection products growing faster than the rest, while preparing for a tougher cost environment. The regulator's final decision on expense limits will decide how comfortable that outlook turns out to be.